Analystreport

Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at Morgan Stanley from $11.00 to $16.00. They now have an "equal weight" rating on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com